Výsledky vyhledávání

Akademický článek

COVID-19 and Nurse-Sensitive Indicators: Using Performance Improvement Teams to Address Quality Indicators During a Pandemic.

Autor: Stifter J; Perioperative and Interventional Services and Professional Nursing Practice (Dr Stifter), Professional Nursing Practice (Dr Sermersheim and Mss Ellsworth and Silvestri), Hematology/Oncology/Stem Cell Transplant, Department of Medicine (Ms Dowding), Department of Medicine (Ms Day), Departments of Adult General Surgery and Medicine (Ms Margwarth), Patient Care Services (Mr Korkmaz and Dr Abraham), Wound/Ostomy Continence Service (Mss Walkowiak, Boudreau, and Hernandez), Rehabilitation Services (Mr Harbert and Dr Ambutas), and Guest Relations (Mr Shaw), Rush University Medical Center, Chicago, Illinois., Sermersheim E, Ellsworth M, Dowding E, Day E, Silvestri K, Margwarth J, Korkmaz K, Walkowiak N, Boudreau L, Hernandez L, Harbert B, Ambutas S, Abraham A, Shaw P

Publikováno v: Journal of nursing care quality [J Nurs Care Qual] 2021 Jan-Mar 01; Vol. 36 (1), pp. 1-6.

Zobrazit plný text záznamu

Akademický článek

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.

Autor: Freedman RA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: rafreedman@partners.org., Gelman RS; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA., Agar NYR; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Randall EC; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Gimenez-Cassina Lopez B; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA., Connolly RM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Dunn IF; Department of Neurosurgery, University of Oklahoma, Oklahoma City, OK., Van Poznak CH; University of Michigan, Ann Arbor, MI., Anders CK; Division of Medical Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC., Melisko ME; Department of Medical Oncology, University of California at San Francisco, San Francisco, CA., Silvestri K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Cotter CM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Componeschi KP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Marte JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Moy B; Massachusetts General Hospital, Boston, MA., Blackwell KL; Department of Medicine, Duke University Medical Center, Durham, NC., Puhalla SL; University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, PA., Ibrahim N; The University of Texas MD Anderson Cancer Center, Houston, TX., Moynihan TJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Nangia J; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Tung N; Beth Israel Deaconess Medical Center, Boston, MA., Burns R; The Emmes Corporation, Rockville, MD., Rimawi MF; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Wolff AC; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2020 Apr; Vol. 20 (2), pp. 145-151.e2. Date of Electronic Publication: 2019 Aug 22.

Zobrazit plný text záznamu

Akademický článek

Brain Metastasis in the Emergency Department: Epidemiology, Presentation, Investigations, and Management.

Autor: Zoghbi, Marianne¹ (AUTHOR) mzoghbi@mdanderson.org, Moussa, Mohammad Jad² (AUTHOR), Dagher, Jim³ (AUTHOR), Haroun, Elio³ (AUTHOR), Qdaisat, Aiham⁴ (AUTHOR), Singer, Emad D.⁵ (AUTHOR), Karam, Yara E.⁶ (AUTHOR), Yeung, Sai-Ching J.⁴ (AUTHOR) syeung@mdanderson.org, Chaftari, Patrick⁴ (AUTHOR) syeung@mdanderson.org

Publikováno v: Cancers. Jul2024, Vol. 16 Issue 14, p2583. 16p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

New Frontiers in the Treatment of Patients with HER2+ Cancer and Brain Metastases: Is Radiotherapy Always Useful?

Autor: Scandurra, Giuseppa^1,2 (AUTHOR) daniela.sambataro@unikore.it, Lombardo, Valentina¹ (AUTHOR) lombardovalentina89@gmail.com, Scibilia, Giuseppe^2,3 (AUTHOR) vittorio.gebbia@unikore.it, Sambataro, Daniela^2,4 (AUTHOR) paolo.scollo@unikore.it, Gebbia, Vittorio^2,5 (AUTHOR) basilio.pecorino@unikore.it, Scollo, Paolo^2,6 (AUTHOR), Pecorino, Basilio^2,7 (AUTHOR), Valerio, Maria Rosaria⁸ (AUTHOR) mariarosaria.valerio@unipa.it

Publikováno v: Cancers. Jul2024, Vol. 16 Issue 13, p2466. 21p.

Zobrazit plný text záznamu

Akademický článek

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.

Autor: Freedman RA; 1 Dana-Farber Cancer Institute, Boston, MA., Gelman RS; 1 Dana-Farber Cancer Institute, Boston, MA., Anders CK; 2 University of North Carolina at Chapel Hill, Chapel Hill, NC., Melisko ME; 3 University of California at San Francisco, San Francisco, CA., Parsons HA; 1 Dana-Farber Cancer Institute, Boston, MA., Cropp AM; 1 Dana-Farber Cancer Institute, Boston, MA., Silvestri K; 1 Dana-Farber Cancer Institute, Boston, MA., Cotter CM; 1 Dana-Farber Cancer Institute, Boston, MA., Componeschi KP; 1 Dana-Farber Cancer Institute, Boston, MA., Marte JM; 1 Dana-Farber Cancer Institute, Boston, MA., Connolly RM; 4 Johns Hopkins School of Medicine, Baltimore, MD., Moy B; 5 Massachusetts General Hospital, Boston, MA., Van Poznak CH; 6 University of Michigan, Ann Arbor, MI., Blackwell KL; 7 Duke University Medical Center, Durham, NC., Puhalla SL; 8 University of Pittsburgh Cancer Institute, Pittsburgh, PA., Jankowitz RC; 8 University of Pittsburgh Cancer Institute, Pittsburgh, PA., Smith KL; 4 Johns Hopkins School of Medicine, Baltimore, MD., Ibrahim N; 9 The University of Texas MD Anderson Cancer Center, Houston, TX., Moynihan TJ; 10 Mayo Clinic, Rochester, MN., O'Sullivan CC; 10 Mayo Clinic, Rochester, MN., Nangia J; 11 Baylor College of Medicine, Houston, TX., Niravath P; 11 Baylor College of Medicine, Houston, TX., Tung N; 12 Beth Israel Deaconess Medical Center, Boston, MA., Pohlmann PR; 13 Lombardi Comprehensive Cancer Center, Washington, DC., Burns R; 14 The Emmes Corporation, Rockville, MD., Rimawi MF; 11 Baylor College of Medicine, Houston, TX., Krop IE; 1 Dana-Farber Cancer Institute, Boston, MA., Wolff AC; 4 Johns Hopkins School of Medicine, Baltimore, MD., Winer EP; 1 Dana-Farber Cancer Institute, Boston, MA., Lin NU; 1 Dana-Farber Cancer Institute, Boston, MA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 May 01; Vol. 37 (13), pp. 1081-1089. Date of Electronic Publication: 2019 Mar 12.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání